» Articles » PMID: 35273564

Mapping Motor Neuron Vulnerability in the Neuraxis of Male SOD1 Mice Reveals Widespread Loss of Androgen Receptor Occurring Early in Spinal Motor Neurons

Overview
Specialty Endocrinology
Date 2022 Mar 11
PMID 35273564
Authors
Affiliations
Soon will be listed here.
Abstract

Sex steroid hormones have been implicated as disease modifiers in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS). Androgens, signalling the androgen receptor (AR), predominate in males, and have widespread actions in the periphery and the central nervous system (CNS). AR translocates to the cell nucleus when activated upon binding androgens, whereby it regulates transcription of target genes the classical genomic signalling pathway. We previously reported that AR protein is decreased in the lumbar spinal cord tissue of symptomatic male SOD1 mice. Here, we further explored the changes in AR within motor neurons (MN) of the CNS, assessing their nuclear AR content and propensity to degenerate by endstage disease in male SOD1 mice. We observed that almost all motor neuron populations had undergone significant loss in nuclear AR in SOD1 mice. Interestingly, loss of nuclear AR was evident in lumbar spinal MNs as early as the pre-symptomatic age of 60 days. Several MN populations with high AR content were identified which did not degenerate in SOD1 mice. These included the brainstem ambiguus and vagus nuclei, and the sexually dimorphic spinal MNs: cremaster, dorsolateral nucleus (DLN) and spinal nucleus of bulbocavernosus (SNB). In conclusion, we demonstrate that AR loss directly associates with MN vulnerability and disease progression in the SOD1 mouse model of ALS.

Citing Articles

Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?.

Proano B, Casani-Cubel J, Benlloch M, Rodriguez-Mateos A, Navarro-Illana E, Lajara-Romance J Biomedicines. 2022; 10(9).

PMID: 36140184 PMC: 9495995. DOI: 10.3390/biomedicines10092084.


Metabolic Dysfunction in Motor Neuron Disease: Shedding Light through the Lens of Autophagy.

De Silva S, Turner B, Perera N Metabolites. 2022; 12(7).

PMID: 35888698 PMC: 9317837. DOI: 10.3390/metabo12070574.

References
1.
Lederer C, Torrisi A, Pantelidou M, Santama N, Cavallaro S . Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics. 2007; 8:26. PMC: 1796866. DOI: 10.1186/1471-2164-8-26. View

2.
Genc B, Jara J, Lagrimas A, Pytel P, Roos R, Marsel Mesulam M . Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS. Sci Rep. 2017; 7:41765. PMC: 5292972. DOI: 10.1038/srep41765. View

3.
Choi J, Levey A, Weintraub S, Rees H, Gearing M, Chin L . Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem. 2004; 279(13):13256-64. DOI: 10.1074/jbc.M314124200. View

4.
Blanco C, Zhan W, Fang Y, Sieck G . Exogenous testosterone treatment decreases diaphragm neuromuscular transmission failure in male rats. J Appl Physiol (1985). 2001; 90(3):850-6. DOI: 10.1152/jappl.2001.90.3.850. View

5.
Yasvoina M, Genc B, Jara J, Sheets P, Quinlan K, Milosevic A . eGFP expression under UCHL1 promoter genetically labels corticospinal motor neurons and a subpopulation of degeneration-resistant spinal motor neurons in an ALS mouse model. J Neurosci. 2013; 33(18):7890-904. PMC: 3963467. DOI: 10.1523/JNEUROSCI.2787-12.2013. View